- $353.89m
- $1.17bn
- $1.88bn
Annual balance sheet for Evolent Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 266 | 188 | 193 | 104 | 152 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 131 | 255 | 447 | 415 | 310 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 524 | 478 | 684 | 607 | 506 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 132 | 137 | 90.2 | 79.3 | 85.2 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,419 | 1,817 | 2,680 | 2,544 | 1,899 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 445 | 433 | 674 | 716 | 385 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 726 | 958 | 1,434 | 1,353 | 1,484 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 694 | 859 | 1,246 | 1,191 | 415 |
| Total Liabilities & Shareholders' Equity | 1,419 | 1,817 | 2,680 | 2,544 | 1,899 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |